Precigen (PGEN) Amortizatization of Intangibles (2013 - 2026)
Precigen (PGEN) reported Amortizatization of Intangibles of $369000.0 for Q1 2026, down 47.73% year-over-year from $706000.0 in Q1 2025, and down 48.25% quarter-over-quarter from $713000.0 in Q4 2025.
Precigen (PGEN) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Amortizatization of Intangibles data on file, last reported at $369000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $369000.0, down 47.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 56.71% YoY), and the FY2025 annual result was $2.2 million, up 149.72% from the prior year.
- Amortizatization of Intangibles fell to $369000.0 in Q1 2026 per PGEN's latest filing, from $713000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $713000.0 in Q4 2025 and troughed at -$265000.0 in Q1 2022.
- A 5-year average of $260823.5 and a median of $318000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 364.91% in 2022, then jumped 412.12% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$165000.0 in 2022, then jumped by 412.12% to $515000.0 in 2023, then sank by 70.68% to $151000.0 in 2024, then jumped by 372.19% to $713000.0 in 2025, then sank by 48.25% to $369000.0 in 2026.
- Business Quant data shows PGEN's Amortizatization of Intangibles at $369000.0 in Q1 2026, $713000.0 in Q4 2025, and $318000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Precigen | 1.38 Bn | 1.38 Bn | 20.69 Mn | 369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369,000.00 |
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 706,000.00 |
| Mar 31, 2025 | 706,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 397,000.00 |
| Mar 31, 2024 | 397,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Dec 31, 2023 | 515,000.00 |